<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput xmlns:ns2="local" id="1678419"><Name>Q3 2007 ISTA Pharmaceuticals, Inc. Earnings Conference Call</Name><Company>ISTA Pharmaceuticals Inc</Company><Drugs><Drug>olopatadine (nasal spray), Alcon</Drug><Drug>hyaluronidase (ovine)</Drug><Drug>bromfenac sodium (once-daily, ocular inflammation), ISTA Pharmaceuticals</Drug><Drug>nepafenac</Drug><Drug>brimonidine</Drug><Drug>ketorolac (ophthalmic), Allergan</Drug><Drug>olopatadine hydrochloride (ophthalmic), Alcon</Drug><Drug>tobramycin + dexamethasone, Alcon Inc</Drug><Drug>loteprednol etabonate + tobramycin (ophthalmic), Bausch &amp; Lomb</Drug><Drug>bepotastine</Drug><Drug>timolol (once-daily eye drop formulation), ISTA/Senju</Drug></Drugs></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput>